These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27501339)

  • 1. Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies.
    Ou YJ; Chiu HF; Wong YH; Yang YH
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1107-1115. PubMed ID: 27501339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
    Oh YH; Yoon C; Park SM
    World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies.
    Ou YJ; Chiu HF; Wong YH; Yang CC; Yang YH
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1286-1295. PubMed ID: 28857419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bisphosphonate use and risk of postmenopausal endometrial cancer.
    Newcomb PA; Passarelli MN; Phipps AI; Anderson GL; Wactawski-Wende J; Ho GY; O'Sullivan MJ; Chlebowski RT
    J Clin Oncol; 2015 Apr; 33(10):1186-90. PubMed ID: 25713431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis.
    Zhang XS; Zhang YM; Li B; Fan B; Zhao Y; Yang SJ
    Gynecol Oncol; 2018 Sep; 150(3):509-514. PubMed ID: 29960711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis.
    Myung SK; Ju W; Choi HJ; Kim SC;
    BJOG; 2009 Dec; 116(13):1697-705. PubMed ID: 19775307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
    Alford SH; Rattan R; Buekers TE; Munkarah AR
    Cancer; 2015 Feb; 121(3):441-7. PubMed ID: 25533883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.
    Liu Y; Zhao S; Chen W; Hu F; Zhu L; Zhang Q; Zhao Y
    Clin Breast Cancer; 2012 Aug; 12(4):276-81. PubMed ID: 22622199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.
    Sun K; Liu JM; Sun HX; Lu N; Ning G
    Osteoporos Int; 2013 Jan; 24(1):279-86. PubMed ID: 23052941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dairy Products Intake and Endometrial Cancer Risk: A Meta-Analysis of Observational Studies.
    Li X; Zhao J; Li P; Gao Y
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29283380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study.
    Spoendlin J; Meier C; Jick SS; Meier CR
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1116-1123. PubMed ID: 27297005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bisphosphonates and the risk of colorectal cancer: a meta-analysis.
    Yang G; Hu H; Zeng R; Huang J
    J Clin Gastroenterol; 2013 Oct; 47(9):741-8. PubMed ID: 24030705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
    Liu Y; Qin A; Li T; Qin X; Li S
    Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drug use and risk of endometrial cancer: A systematic review and meta-analysis of observational studies.
    Verdoodt F; Friis S; Dehlendorff C; Albieri V; Kjaer SK
    Gynecol Oncol; 2016 Feb; 140(2):352-8. PubMed ID: 26701413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate Use and Risk of Implant Revision after Total Hip/Knee Arthroplasty: A Meta-Analysis of Observational Studies.
    Teng S; Yi C; Krettek C; Jagodzinski M
    PLoS One; 2015; 10(10):e0139927. PubMed ID: 26444555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies.
    Wu QJ; Li YY; Tu C; Zhu J; Qian KQ; Feng TB; Li C; Wu L; Ma XX
    Sci Rep; 2015 Sep; 5():14243. PubMed ID: 26373341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
    Tao MH; Chen S; Freudenheim JL; Cauley JA; Johnson KC; Mai X; Sarto GE; Wakelee H; Boffetta P; Wactawski-Wende J
    Ann Oncol; 2018 Jun; 29(6):1476-1485. PubMed ID: 29617712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of bisphosphonates on the risk of endometrial and ovarian malignancies.
    Rennert G; Rennert HS; Pinchev M; Lavie O
    Gynecol Oncol; 2014 May; 133(2):309-13. PubMed ID: 24556062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breastfeeding and the incidence of endometrial cancer: A meta-analysis.
    Zhan B; Liu X; Li F; Zhang D
    Oncotarget; 2015 Nov; 6(35):38398-409. PubMed ID: 26384296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and the risk of ovarian and endometrial cancers: a meta-analysis.
    Wang Y; Ren F; Song Z; Chen P; Liu S; Ouyang L
    BMC Cancer; 2019 Jul; 19(1):730. PubMed ID: 31340777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.